Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 2 Hydroxy Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel acetamidase mutant enables high-purity chiral acid production. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101941900A details a novel ruthenium-catalyzed asymmetric hydrogenation route for high-purity ACE inhibitor intermediates, offering significant cost reduction and supply chain stability.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN120796399A reveals a high-yield enzymatic route for this chiral intermediate. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN108727187A details a high-purity synthesis route for herbicide intermediates. This report analyzes cost reduction and supply chain reliability for global procurement.